MODERN APPROACH TOWARDS IMMUNOMODULATION THERAPY
https://doi.org/10.15690/vsp.v11i1.146
Abstract
This article covers one of the most discussed issues of clinical immunology — the role of dendritic cells in acquired immunity. Modern conception of dendritic cells participating in antigen handling procedure and its presentation, interaction with other immune cells made it possible to change approach towards immunomodulating therapy dramatically and to develop a new class of immunostimulants, that influence simultaneously cell and humoral immunity both in loci of antigen intervention on the mucosal level and systemically.
About the Authors
L. S. Namazova-Baranova
Scientific Centre of Children’s Health RAMS, Moscow;
Sechenov First Moscow Medical University
Russian Federation
Russian Federation
E. A. Vishneva
Scientific Centre of Children’s Health RAMS, Moscow
Russian Federation
Elena Aleksandrovna Vishneva, MD, senior research scientist of the Department of Hospital-replacing technologies, allergologist and immunologist of the Department of Remedial treatment of Children with hypersensitivity diseases and diseases of the respiratory system of RI of Preventive Pediatrics and Remedial treatment of SCCH of RAMS
Russian Federation
Elena Aleksandrovna Vishneva, MD, senior research scientist of the Department of Hospital-replacing technologies, allergologist and immunologist of the Department of Remedial treatment of Children with hypersensitivity diseases and diseases of the respiratory system of RI of Preventive Pediatrics and Remedial treatment of SCCH of RAMS
References
1. Steinman R. M., Banchereau J. Taking Dendritic Cells into Medicine // Nature. — 2007; 449: 419–426.
2. Харит С. М., Начарова Е. П., Намазова-Баранова Л. С. и соавт. Эффективность пидотимода для профилактики респира- торных заболеваний у детей // Детские инфекции. — 2010; 4: 32–36.
3. Sheng К. С., Pietersz G. A., Wright M. D. et al. Dendritic cells: activation and maturation applications for cancer immunotherapy // Curr. Med. Chem. — 2005; 12: 1783–1800.
4. Аллергия у детей: от теории к практике / под ред. Л. С. Намазовой-Барановой. — М.: Союз педиатров России, 2010–2011. — 668 с.
5. Donnini A., Argentari K., Mancini R. et al. Phenotype, antigenpresenting capacity, and migration of antigen-presenting cells in young and old age // Exp. Gerontol. — 2002; 37: 1097–1112.
6. Rharbaoui F., Drabner B., Borsutzky S. et al. The mycoplasmaderived lipopeptide MALP-2 is a potent mucosal adjuvant // Eur. J. Immunol. — 2002; 32: 2857–2865.
7. Fiorentini S., Becker P. D., Marini E. et al. HIV-1 matrix protein pl7 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens // Viral. Immunol. — 2006; 19: 77–88.
8. Riboldi P., Gerosa M., Meroni P. L. Pidotimod: a reappraisal // Int. J. Immunopathol. Pharmacol. — 2009; 22 (2): 255–262.
9. Marelli P., Lupetti A., Senesi S. et al. Potenziamento della resistenza alle infezioni virali e batteriche dopo somministrazione di Pidotimod nel topo // Drugs. Exp. Clin. Res. — 1993; 19: 15–21.
10. Careddu P., Biolchini A., Alfano S., Zavattini G. Pidotimod in the prophylaxis of recurrent acute tonsillitis in childhood // Adv. Otorhinolaryngol. — 1992; 47: 328–331.
11. Careddu P. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood // Drug. Res. — 1994; 44: 1506–1511.
12. Aivazis V., Hatzimichail A., Papachristou A. et al. Clinical evaluation and changes of the respiratory epithelium function after administration of pidotimod in Greek children with recurrent respiratory tract infections // Minerva Pediatr. — 2002; 54: 315–319.
13. Giagulli C., Noerder M., Avolio M. et al. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level // Int. Immunopharmacol. — 2009; 9 (12): 1366–1373.
Review
For citations:
Namazova-Baranova L.S., Vishneva E.A. MODERN APPROACH TOWARDS IMMUNOMODULATION THERAPY. Current Pediatrics. 2012;11(1):143-146. (In Russ.) https://doi.org/10.15690/vsp.v11i1.146
Views:
694
Email this article 
